RetroNectin Pro¢ç - G-Rex ½Ã½ºÅÛ¿¡¼µµ T-cell ¹è¾ç°ú transductionÀ» Çѹø¿¡!!
¾È³çÇϼ¼¿ä, ´ÙÄ«¶óÄÚ¸®¾ÆÀÔ´Ï´Ù.
T-cellÀÇ È®´ë¹è¾çºÎÅÍ virusÀÇ transduction±îÁö Çѹø¿¡ ÁøÇàÇÏ´Â RetroNectin¢çÀÌ ´õ¿í professionalÇÑ ½ÅÁ¦Ç°À¸·Î µ¹¾Æ¿Ô½À´Ï´Ù.
CGT¿¡¼ ´ë·® »ý»êÀ» À§ÇØ ¸¹ÀÌ »ç¿ëÇÏ´Â °¡½º Åõ°ú¼º ¿ë±â (G-Rex¢ç Bioreactor ½Ã¸®Áî)¿¡ ´ëÇÑ applicationÀÌ Ãß°¡µÇ¾ú°í, ±âÁ¸ Á¦Ç°°ú µ¿ÀÏÇÑ ¼º´É ¹× ÇÁ·ÎÅäÄÝ¿¡ °¡°ÝÀ» ³·Ãç ´õ¿í ÇÕ¸®ÀûÀ¸·Î »ç¿ëÇÏ½Ç ¼ö ÀÖµµ·Ï ÁغñÇß½À´Ï´Ù.
Code |
Á¦Ç°¸í |
¿ë·® |
T101A |
RetroNectin¢ç
Pro (Recombinant Human Fibronectin Fragment) |
0.5 §· (0.5 §¢) |
T101B |
RetroNectin¢ç
Pro (Recombinant Human Fibronectin Fragment) |
0.5 §· (0.5 §¢) |
Âü°í¹®Çå:
Mapping variant effects on anti-tumor hallmarks of primary
human T cells with base-editing screens
Zachary
H.Walsh, Parin Shah, Neeharika Kothapalli, et al., Nature Biotechnology (2024)
±×¸² 1. G-Rex 24
well plateÀÇ À¯ÀüÀÚ Àü´Þ ¹× È®´ë¹è¾ç ¹æ¹ý
Á¦Ç° °ü·Ã ¹®ÀÇ´Â °í°´Áö¿ø(02-2081-2510,
support@takara.co.kr)À¸·Î ¿¬¶ô¹Ù¶ø´Ï´Ù.
°¨»çÇÕ´Ï´Ù.